Erlotib 150Mg Tab Substitute

Substitutes of Erlotib 150Mg Tab meet the same safety and efficacy standards as Erlotib 150Mg Tab, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Erlotib 150Mg Tab may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Erlotib 150Mg Tab if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Erlotib 150Mg Tab for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Erlotib 150Mg Tab is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Erlotib 150Mg Tab to its substitute. Always consult your doctor before switching.

Erlotib 150Mg Tab is used to treat lung and pancreatic cancer.

Erlotib 150Mg Tab contains Erlotinib, an anti-cancer medication that works by preventing the activity of a protein called epidermal growth factor receptor (EGFR) and hence induces cell death (apoptosis). As a result, the growth and spread of cancer cells in stopped or slowed down.

The most common sign of lung cancer is a cough that lasts long and gets worse with time. Sometimes, a patient may notice blood in the cough. Chest pain is also a sign of lung cancer followed by coughing.

Erlotib 150Mg Tab is safe to be taken by a diabetic person. However, take Erlotib 150Mg Tab only after asking with a doctor as they may adjust the dosing according to the patient's condition.

In elderly patients, the risk of side effects is more if you are taking Erlotib 150Mg Tab. For the patients who are elderly, dose adjustment might be required or your doctor might prescribe any other medication safe for the elderly.

Erlotib 150Mg Tab can make you more likely to get infections or may worsen any current infections. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu). Consult your doctor if you have been exposed to an infection or for more details.

No, It is advised to maintain a gap between both the medicines, as use of antacids along with Erlotib 150Mg Tab may affect the way the Erlotib 150Mg Tab works. Consult your doctor for further information.

Erlotib 150Mg Tab should be used with caution in patients using anticoagulants. Erlotib 150Mg Tab may increase your tendency to bleed. Talk to your doctor, he will need to regularly monitor you with some blood tests.

Erlotib 150Mg Tab is not recommended for children under 18 years of age, as its safety and efficacy were not established.

No, you should not take Erlotib 150Mg Tab if you are pregnant or planning to become pregnant as it may cause harm to an unborn baby. Consult the doctor if you have any concerns.

No, do not take Erlotib 150Mg Tab with food. It can be taken orally on an empty stomach, at least 1 hour before or 2 hours after meals.

Erlotib 150Mg Tab is a targeted therapy used to treat specific types of non-small cell lung cancer that spread to nearby tissues or any other parts of the body in patients who have previously undergone at least one chemotherapy treatment without improvement.

Erlotib 150Mg Tab should be taken for as long as your doctor has prescribed it, depending on your medical condition. Please consult the doctor if you have any concerns regarding the duration of treatment.

Yes, Smoking may interfere with Erlotib 150Mg Tab. It lowers the levels of Erlotib 150Mg Tab in the blood, potentially reducing its effectiveness in treating the cancer. Avoid smoking while on treatment with Erlotib 150Mg Tab to treat your condition effectively.

Inform the doctor if you notice a rash while taking Erlotib 150Mg Tab as it could be a symptom of an allergic reaction.

Erlotib 150Mg Tab may harm the foetus. Therefore, it is not recommended to become pregnant during treatment with Erlotib 150Mg Tab. Use effective birth control while taking Erlotib 150Mg Tab and for at least one month after your final dose. Talk to the doctor if you plan to become pregnant; the doctor will provide guidance on the same.

Erlotib 150Mg Tab may cause sparse eyelashes (thinning of eyelashes), blepharitis (inflammation of eyelids), and diffuse conjunctival congestion (redness of the eye). Consult the doctor if you notice any eye problems.

Call your doctor if you experience severe diarrhoea, nausea, vomiting, loss of appetite, worsening shortness of breath or cough, new or worsening rash, blistering or peeling of the skin, eye irritation or any changes in smoking habits during treatment with Erlotib 150Mg Tab.